Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: A case report
Article in Clinical Case Reports (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Oral famotidine reduces the plasma level of soluble P‐selectin in children with sickle cell disease
Article in British Journal of Haematology (September 2023)
Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case report
Article in Hematology (July 2023)